Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Francisco, California 94143


Purpose:

To assess the safety and tolerability of 7.5, 15 and 30 mg of sublingual lobeline.


Study summary:

The primary objective of this study is to characterize the pharmacokinetics of three ascending doses of lobeline in normal volunteers.


Criteria:

Inclusion Criteria: - Healthy individuals with a body mass index between 18 and 30. - Willing and able to give written consent. - Must have a negative drug test - Females must have a negative pregnancy test prior to study drug administration - Must have no medical contraindications as determined by routine testing Exclusion Criteria: - Please contact the site for more information


NCT ID:

NCT00100074


Primary Contact:

Principal Investigator
Reese Jones, M.D.
Langley Porter Psychiatric Institute


Backup Contact:

N/A


Location Contact:

San Francisco, California 94143
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 16, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.